Palomäki Ville A B, Laitinen Jarmo T
Department of Physiology, University of Kuopio, POB 1627, FIN-70211 Kuopio, Finland.
Br J Pharmacol. 2006 Mar;147(6):596-606. doi: 10.1038/sj.bjp.0706671.
The basic secretagogues, such as compound 48/80 (c48/80) and mastoparans, are widely used histamine-releasing agents and their mechanism of action is commonly attributed to a direct, receptor-bypassing property to activate the G(i/o) class of G proteins. We tested here whether c48/80 could directly stimulate [(35)S]guanosine-5'-[gamma-thio]triphosphate ([(35)S]GTPgammaS) binding to rat brain sections in an attempt to visualize the entire signaling pool of G(i/o) in its native neuroanatomical context. Instead of direct G(i/o) activation, c48/80 (100 microg ml(-1)) from various suppliers stimulated brain phospholipase D (PLD) activity, leading to the generation of endogenous phospholipids capable of activating brain white matter-enriched, G(i/o)-coupled lysophosphatidic acid (LPA) receptors. This response was sensitive to 1-butanol and was potently reversed by the LPA(1)/LPA(3) receptor-selective antagonist Ki16425 (IC(50) 59+/-13 nM, mean+/-s.e.m.), and showed age-dependent decline, closely reflecting known developmental regulation of the PLD-LPA(1) receptor axis in the CNS. In addition, c48/80 was found to modestly activate hippocampal 5-HT(1A) receptors in a pH-dependent and antagonist-sensitive manner. Consistent with the lack of direct G(i/o)-activating properties in brain sections, c48/80 showed no activity in classical membrane [(35)S]GTPgammaS binding assays. Instead, c48/80 from one particular manufacturer elicited non-specific effect in these assays, therefore challenging the previous interpretations regarding the compound's ability to activate G proteins directly. We conclude that c48/80 is not a receptor-bypassing general G protein activator but rather activates PLD, leading to generation of endogenous LPA receptor-activating phospholipids. This property may also contribute to the compound's ability to release histamine from mast cells.
基本促分泌剂,如化合物48/80(c48/80)和mastoparans,是广泛使用的组胺释放剂,其作用机制通常归因于一种直接的、绕过受体的特性,以激活G(i/o)类G蛋白。我们在此测试了c48/80是否能直接刺激[(35)S]鸟苷-5'-[γ-硫代]三磷酸([(35)S]GTPγS)与大鼠脑切片的结合,试图在其天然神经解剖背景下可视化G(i/o)的整个信号池。与直接激活G(i/o)不同,来自不同供应商的c48/80(100μg ml(-1))刺激了脑磷脂酶D(PLD)活性,导致能够激活富含脑白质的、G(i/o)偶联的溶血磷脂酸(LPA)受体的内源性磷脂的产生。这种反应对1-丁醇敏感,并被LPA(1)/LPA(3)受体选择性拮抗剂Ki16425有效逆转(IC(50) 59±13 nM,平均值±标准误),并显示出年龄依赖性下降,密切反映了中枢神经系统中已知的PLD-LPA(1)受体轴的发育调节。此外,发现c48/80以pH依赖性和拮抗剂敏感的方式适度激活海马5-HT(1A)受体。与脑切片中缺乏直接激活G(i/o)的特性一致,c48/80在经典的膜[(35)S]GTPγS结合试验中没有活性。相反,来自一个特定制造商的c48/80在这些试验中引发了非特异性效应,因此对先前关于该化合物直接激活G蛋白能力的解释提出了挑战。我们得出结论,c48/80不是一种绕过受体的通用G蛋白激活剂,而是激活PLD,导致产生内源性LPA受体激活磷脂。这种特性也可能有助于该化合物从肥大细胞释放组胺的能力。